SP5B Astrotech Corp

Astrotech’s Subsidiary 1st Detect Wins Gold at ‘ASTORS’ Homeland Security Awards as Best CBRNE Detection System

Astrotech Corporation (NASDAQ: ASTC) announced today that its 1st Detect subsidiary has received a Gold Award for its TRACER 1000 explosives trace detector (ETD) in the Best CBRNE Detection System category at American Security Today’s ‘ASTORS’ Homeland Security Awards program.

“We are honored and humbled to receive the award, as it is a recognition of our core philosophy of differentiation through innovation,” said Raj Mellacheruvu, Chief Executive Officer of 1st Detect. “It has long been known that mass spectrometry is the superior technology for detecting explosives. We have solved the ease of use and ruggedness challenges of traditional mass spectrometry and we now have instruments deployed and in service throughout Europe. In addition, with our near zero false alarms, our instruments cost less than the competing technology and we are quickly becoming recognized as technological leaders in the industry.”

The Annual ‘ASTORS’ Awards, now in its fifth year, is the preeminent U.S. Homeland Security Awards Program, highlighting the most cutting-edge and forward-thinking security solutions coming onto the market today. The program is specifically designed to honor distinguished government and vendor solutions that deliver enhanced value, benefit and intelligence to end users in a variety of government, homeland security, enterprise and public safety vertical markets.

“Today, the United States is increasingly focusing on protecting public spaces, as well as IT/cybersecurity networks, and they are calling on innovative companies like 1st Detect to help them do so,” according to Tammy Waitt, co-founder and editorial director of American Security Today. “‘ASTORS’ nominations are evaluated on their technical innovation, interoperability, specific impact within the category, overall impact to the industry, relatability to other industry technologies and application feasibility outside of the industry.”

The TRACER 1000 is the only certified ETD that uses mass spectrometry, the world’s gold standard instrumentation used to identify complex chemical compounds. Checkpoint and cargo certification was received from the European Civil Aviation Conference (ECAC) enabling TRACER 1000 sales in Europe and much of the rest of the world. Additionally, on September 9, 2020, the TRACER 1000 passed the non-detection testing of the U.S. Transportation Security Administration’s (TSA) Air Cargo Screening Technology Qualification Test (ACSQT). Upon successful completion of detection testing, which is the next and final phase, the TRACER 1000 will be added to the Air Cargo Screening Technology List (ACSTL) as an “approved” ETD for sales to the cargo screening market within the United States.

“After many years of hard work, innovation and investment, we are poised for continued growth in the security industry which will be followed by product introductions in the fields of agriculture and medicine. This is an exciting time as we begin our scale cycle and we are pleased to have our superior technology be recognized by a leading voice in the security industry,” concluded Mellacheruvu.

About Astrotech Corporation

Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. develops, manufactures, and sells trace detectors for use in the security and detection market. Astrotech is headquartered in Austin, Texas. For information, please visit .

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.

EN
21/12/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Astrotech Corp

 PRESS RELEASE

Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadl...

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022. The 2022 Annual Meeting will be held at 9:00 a.m. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the Company’s main office. The Company anticipates sending proxy materials for the annual meeting to stockholders in September 2022. Astrotech Corporation 2022 Annual Meeting of Stockholders Astrotech Corporation Main Office 2105 Donley Dri...

 PRESS RELEASE

Astrotech Appoints Jim Becker to Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) announced today that it has appointed Jim Becker to its Board of Directors. Mr. Becker brings to Astrotech’s Board extensive leadership, with a focus on strategic market growth and expansion, and business process improvements and scaling, along with public speaking and corporate management skills. He will serve on each of the compensation committee, the corporate governance and nominating committee, and the audit committee of the Board of Directors. Mr. Becker stated, “I look forward to joining the Board of Astrotech. With ...

 PRESS RELEASE

Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study...

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation, announced today that it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus. Under the amended agreement, ongoing work around development of a rapid breath test for COVID-19 will be expanded to utilize BreathTech’s core mass spectrometry technology to screen for a variety of diseases spanning the entire body. The project will focus on detecting bloodstream infections, respiratory infections such as influenza types A and B and ...

 PRESS RELEASE

Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022. Astrotech's subsidiary 1st Detect continues sales of its TRACER 1000™ solution, the first and only mass spectrometry-based explosives trace detector (ETD) certified by the European Civil Aviation Conference (ECAC) for air and cargo security, with revenue related to the TRACER 1000 up 161% to $845 thousand for the nine months ended March 31, 2022, compared to the same period one year ago. The T...

 PRESS RELEASE

Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021. Astrotech had its best quarter since sales of 1st Detect’s TRACER 1000™ began, with revenue related to the TRACER 1000 up 332% compared to the same period one year ago. After garnering initial traction in the cargo security market due to the TRACER 1000’s near-zero false alarm rate, in the second quarter, 1st Detect completed a major milestone by fulfilling its first purchase order for air...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch